The impact to revenues for the three and six months ended June 30, 2018 related to these adjustments was a decrease of $9.6 million and $21.4 million, respectively.
The effective tax rate was (61.1)% and 18.1% for the three months ended June 30, 2018 and 2017, respectively and (87.7)% and 17.8% for the six months ended June 30, 2018 and 2017, respectively.
Public offering.
The change in the effective tax rate for the three months ended June 30, 2018 and six months ended June 30, 2018 was primarily due to the acquisition of DST and the relative proportionate impact of permanent book to tax differences on reduced pre-tax book income in 2018.
The Company’s healthcare solutions include claims adjudication, benefit management, care management, business intelligence and other ancillary services.
The amount of revenues recognized in the period that was included in the opening deferred revenues balance was $54.4 million and $131.0 million for the three and six months ended June 30, 2018, respectively.
The increase in investments was the result of acquiring the net assets of DST in the second quarter of 2018.
The Company reported revenues of $0.8 million and $471.9 million from CACEIS and DST, respectively, from their respective acquisition dates through June 30, 2018.
Under these arrangements, the client does not have the right to take possession of the software, rather, the Company agrees to provide access to its applications, remote use of its equipment to process transactions, access to client’s data stored on its equipment, and connectivity between its environment and the client’s computing systems.
The Company also offers subscription-based on-demand software applications that are managed and hosted at the Company’s facilities.We had other income, net of $0.6 million and $1.1 million for the three and six months ended June, 30, 2018, respectively.
These facilities are discussed further in “Liquidity and Capital Resources”.
Interest expense, net.
These decreases were partially offset by cash provided by operations and proceeds from stock option exercises.
The increase in cash, cash equivalents and restricted cash and cash equivalents is primarily due to proceeds received from our borrowings and common stock offering, the impact of restricted cash and cash equivalents held by DST as well cash provided by operations and proceeds from stock option exercises.
Transaction expenses are those costs which are directly related to our acquisition of DST.
The favorable impact from foreign currency translation was $2.3 million.During the six months ended June 30, 2018, approximately 28% of our revenues were from clients located outside the United States.